Top Markets
#1 Fabric Protocol Fabric Protocol +32.06%
#2 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +31.94%
#3 Tutorial Tutorial +31.67%
#4 Bitcoin Cash Bitcoin Cash +31.12%
#5 GALA GALA +30.99%
#6 Audiera Audiera +30.55%
#7 Zora Zora +26.33%
#8 GoPlus Security GoPlus Security +26.04%
#9 Arowana Arowana +25.32%
#10 Talus Network Talus Network +24.98%
Coin of the day
Fabric Protocol Fabric Protocol
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Classement en actions #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Prix de l'action
$0.78611575
Capitalisation boursière
$60.45M
Changement (1 jour)
0.00%
Changement (1 an)
-12.06%
Pays
NO
Échange Lytix Biopharma AS (LYTIX)

Catégorie

Healthcare
Ratio P/B pour Lytix Biopharma AS (LYTIX)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Lytix Biopharma AS, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Lytix Biopharma AS de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH